Participation rates similar for Black and White patients, treatment and cancer control trials

Pulmonary complication, postoperative SARS-CoV-2 infection rates lower with COVID-19-free pathways

Guidelines reduce postoperative opioid prescribing but may result in inadequate pain control for some

Use of ACE-I/ARB versus nonuse linked to lower mortality for those hospitalized with flu, pneumonia

No infection identified among surgeons following procedure; postoperative complications rarely seen

However, no significant difference in mortality found between remdesivir and placebo groups

Combined MICT, HIIT intervention group had no difference in mortality versus recommended guidelines

Most older adults taking multiple medications have never had a comprehensive medication review

No reductions seen in 28-day mortality or duration of hospital stay in COVID-19 with lopinavir-ritonavir

If enough people in the U.S. pass on vaccine, the nation may not be able to achieve herd immunity